XENE

Xenon Pharmaceuticals Inc.

Biotechnology · Biotechnology

$177.56 sample

-0.88 (-0.49%) 1D

Market cap

$995.4B

Price as of

2026-10-16

Latest filing

8-K · 2026-10-08

Alerts

8

Price$177.56 -7.38% 3M daily closessample

191.70159.70

2026-07-212026-08-122026-09-032026-09-242026-10-16

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08SECForm 144 filed
Oct 02INSInsider buy: Director
Sep 28INSInsider sell: 10% owner
Sep 18INSInsider buy: Director
Sep 10INSInsider sell: EVP, Operations
Sep 03INSInsider sell: 10% owner
Aug 28INSInsider sell: 10% owner
Aug 20SEC10-Q filed

Sign up to see the real XENE record →

Company facts

SEC EDGAR registration

Name: Xenon Pharmaceuticals Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +2sample, -100 to +100
Reporting currency: USD

Who is positioning in XENE

sample

Insiders: 16 insider transactions over 90 days, net selling, $482.1M
Congress: 2 members traded over 90 days
Institutions · 13F: 25 funds hold $7.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$60.7B +18.4% y/y

Q4 2024Q3 2026

Inventory$38.4B +17.9% y/y

Q4 2024Q3 2026

Accounts receivable$28.6B +10.3% y/y

Q4 2024Q3 2026

Total debt$73.8B +17.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $359.1B -2.5% 3M
Sample peer B: $629.7B -5.6% 3M
Sample peer C: $822.4B -12.2% 3M
Sample peer D: $316.0B +7.2% 3M
Sample peer E: $399.3B -6.4% 3M